| Financial Year |
March 31 2023 |
| Monetary Funds |
1,385,193,692.80 |
| Held-for-trading Financial Assets |
743,973,902.90 |
| Notes Receivable |
559,161.88 |
| Accounts Receivable |
481,230,309.44 |
| Advances to Suppliers |
77,928,950.44 |
| Other Receivables |
36,573,751.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,557,744,801.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,291,640.58 |
| Total Current Assets |
4,339,496,211.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,750,219.26 |
| Investment Properties |
-- |
| Fixed Assetes |
933,357,500.75 |
| Under-construction Projects |
151,805,934.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
301,440,287.87 |
| R&D expenses |
-- |
| Goodwill |
131,024,537.91 |
| Long-Term Deferred and Prepaid Expenses |
93,831,685.52 |
| Deferred Income Tax Assets |
210,420,005.35 |
| Other Non-Current Assets |
52,079,236.06 |
| Sub-Total of Non-Current Assets |
2,602,208,983.41 |
| Total Assets |
6,941,705,194.46 |
| Short-Term Loans |
335,327,527.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,899,489.16 |
| Accounts Payable |
455,261,922.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
115,512,237.83 |
| Taxes Payable |
126,680,107.50 |
| Interest Payable |
-- |
| Dividend Payable |
9,734,080.00 |
| Other payables |
189,021,073.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
84,755,648.31 |
| Other Current Liabilities |
183,466,712.82 |
| Sub-Total of Current Liabilities |
1,716,359,961.11 |
| Long-term Loans |
400,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
85,423,731.39 |
| Other Non-Current Liabilities |
93,739.99 |
| Sub-Total of Non-Current Liabilities |
863,313,525.94 |
| Total Liabilities |
2,579,673,487.05 |
| Paid-In Capital(Or Share Stock) |
839,114,481.00 |
| Capital Surplus |
789,820,995.20 |
| Surplus Reserve |
477,470,823.10 |
| LESS:Treasury Stock |
46,109,520.00 |
| Undistributed Profits |
2,182,604,224.52 |
| Minority Stockholder's Interest |
25,275,469.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,336,756,238.34 |
| Owner's Equity（Stockholder's Equity） |
4,362,031,707.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,941,705,194.46 |
